SCHEMBL11380422

SCHEMBL11380422

Cn1c(=O)c2c(ncn2COCc2ccccc2)n(C)c1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 5/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
RXFP1 Q9HBX9 2/20 0.70
ALDH1A1 P00352 2/20 0.69
TSHR P16473 1/20 0.66
CASP1 P29466 1/20 0.59
MAOA P21397 2/20 0.58
MAOB P27338 2/20 0.58
PKM P14618 1/20 0.58
TP53 P04637 1/20 0.57
GLA P06280 1/20 0.56
HTT P42858 1/20 0.56
UBE2N P61088 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
LMNA P02545 3/20 0.55
MAPK1 P28482 1/20 0.55
CNOT7 Q9UIV1 1/20 0.55
MAPT P10636 1/20 0.54
POLB P06746 1/20 0.54
HIF1A Q16665 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11387907 0.85 PDE1A (0.74) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL11393503 0.85 ADORA2B (0.63) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL11386372 0.83 SMN1; SMN2 (0.65) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL1944405 0.83 ADORA2B (1.00) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL17786242 0.82 ALDH1A1 (1.00) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL11374923 0.81 ADORA2B (0.62) ADORA2BSMN1; SMN2RXFP1LMNAMAPK1
SCHEMBL19036787 0.80 ADORA2B (0.69) ADORA2BSMN1; SMN2RXFP1ALDH1A1LMNA
SCHEMBL11380544 0.79 ADORA2B (0.59) ADORA2BSMN1; SMN2RXFP1LMNAMAPT
SCHEMBL7459561 0.79 POLB (0.65) ADORA2BSMN1; SMN2RXFP1ALDH1A1TSHR
SCHEMBL13659055 0.78 SMN1; SMN2 (0.66) ADORA2BSMN1; SMN2RXFP1CASP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4061753-A Treating psoriasis with transient pro-drug forms of xanthine derivatives INTERX RESEARCH CORPORATION (US) 1977-12-06 US claimed
US-4275064-A Transient pro-drug forms of xanthine derivatives and their use as topical anti-inflammatory agents INTERX RESEARCH CORPORATION (US) 1981-06-23 US disclosed
US-4061753-A Treating psoriasis with transient pro-drug forms of xanthine derivatives INTERX RESEARCH CORPORATION (US) 1977-12-06 US disclosed